PG vs PHAT · P/E 25, rev $84.28B vs rev $55.3M
Procter & Gamble Company (PG) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the PG and PHAT stock pages for the full models.
Not investment advice.